HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keiji Nogami Selected Research

Hemophilia A (Haemophilia)

9/2022Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy.
9/2022Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
4/2022Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.
2/2022Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.
2/2022Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan.
1/2022AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.
1/2022AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors.
1/2022Heterogeneous coagulant potential of emicizumab in neonatal factor VIII-deficient plasma.
10/2021Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A.
6/2021Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keiji Nogami Research Topics

Disease

60Hemophilia A (Haemophilia)
09/2022 - 05/2005
39Hemorrhage
09/2022 - 11/2014
13Thrombosis (Thrombus)
09/2022 - 09/2010
6Thrombotic Microangiopathies
03/2021 - 09/2016
4Disease Progression
08/2022 - 01/2020
4Disseminated Intravascular Coagulation
11/2021 - 06/2018
4Thromboembolism
01/2020 - 01/2019
3Type 2 von Willebrand Disease
03/2021 - 03/2020
3Joint Diseases (Joint Disease)
01/2020 - 11/2015
2Streptococcal Infections (Streptococcal Infection)
08/2022 - 01/2018
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/2022 - 02/2017
2Thrombophilia
07/2022 - 07/2021
2Hemophilia B (Haemophilia B)
01/2022 - 01/2017
2Sepsis (Septicemia)
11/2021 - 09/2020
2Protein C Deficiency
07/2021 - 06/2019
2Autoimmune Diseases (Autoimmune Disease)
03/2021 - 01/2015
2von Willebrand Diseases (von Willebrand's Disease)
05/2019 - 02/2015
2Myocardial Infarction
12/2012 - 09/2010
1Type 3 von Willebrand Disease
09/2022
1Infantile Spasms (West Syndrome)
09/2022
1Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2022
1COVID-19
06/2022
1Lymphoma (Lymphomas)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Cytokine Release Syndrome
01/2022
1Rare Diseases (Rare Disease)
07/2021
1Hyperammonemia
07/2021
1Intrahepatic Cholestasis
04/2021
1Neonatal-onset citrullinemia type 2
04/2021
1Adult-onset citrullinemia type 2
04/2021
1Biliary Atresia
04/2021
1Infections
03/2021
1Hypoprothrombinemias (Prothrombin Deficiency)
03/2021
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2021
1Diamond-Blackfan Anemia (Anemia, Diamond Blackfan)
03/2021
1Thrombasthenia (Glanzmann Thrombasthenia)
02/2021
1Intellectual Disability (Idiocy)
11/2020
1Malnutrition (Nutritional Deficiencies)
11/2020
1Metrorrhagia (Spotting)
01/2020
1Factor X Deficiency
01/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1Contusions
01/2020
1Pulmonary Hypertension
10/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2019

Drug/Important Bio-Agent (IBA)

30emicizumabIBA
09/2022 - 11/2014
26Factor VIII (Coagulation Factor VIII)IBA
09/2022 - 05/2005
23Hemostatics (Antihemorrhagics)IBA
09/2022 - 11/2014
9von Willebrand FactorIBA
09/2022 - 02/2015
9ThrombinFDA Link
08/2022 - 12/2009
9prothrombin complex concentrates (PPSB)IBA
03/2021 - 01/2007
8Blood Coagulation Factors (Coagulation Factor)IBA
04/2021 - 01/2007
7FibrinIBA
08/2022 - 06/2018
6FibrinolysinFDA Link
08/2022 - 07/2017
6Thromboplastin (Tissue Factor)IBA
07/2022 - 12/2009
6CoagulantsIBA
10/2021 - 01/2020
4Protein CIBA
07/2022 - 10/2018
4Dacarbazine (DIC)FDA LinkGeneric
11/2021 - 06/2018
4AnticoagulantsIBA
04/2021 - 11/2015
4AutoantibodiesIBA
01/2020 - 02/2012
3Immunoglobulin G (IgG)IBA
09/2022 - 01/2018
3recombinant FVIIa (rFVIIa)FDA Link
06/2021 - 01/2020
3Factor X (Stuart Factor)IBA
01/2020 - 06/2013
2AntibodiesIBA
09/2022 - 03/2021
2Prothrombin (Factor II)IBA
08/2022 - 01/2020
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
06/2021 - 03/2021
2Fibrinogen (Factor I)FDA Link
04/2021 - 06/2018
2Protein SIBA
04/2021 - 09/2016
2Factor VIIIaIBA
03/2021 - 01/2021
2CollagenIBA
02/2021 - 03/2020
2factor VIII-Fc fusion proteinIBA
05/2020 - 01/2016
2Factor IXa (Coagulation Factor IXa)IBA
01/2020 - 11/2014
2Ellagic AcidIBA
01/2020 - 12/2009
2Monoclonal AntibodiesIBA
09/2019 - 10/2017
1Adrenocorticotropic Hormone (ACTH)FDA Link
09/2022
1PlasminogenIBA
08/2022
1StreptokinaseFDA Link
08/2022
1ThrombomodulinIBA
07/2022
1Proteins (Proteins, Gene)FDA Link
07/2022
1formycin diphosphate (FDP)IBA
06/2022
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1tisagenlecleucelIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1AntithrombinsIBA
04/2021
1VitaminsIBA
04/2021
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2021
1Asparaginase (Elspar)FDA Link
01/2020
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
10/2019

Therapy/Procedure

27Therapeutics
09/2022 - 01/2007
3Liver Transplantation
07/2021 - 01/2016
2Synovectomy
06/2021 - 08/2018
2Intravenous Infusions
01/2021 - 05/2016
2Subcutaneous Infusions
01/2020 - 05/2016
2Injections
08/2018 - 11/2014
2Intravenous Administration
01/2017 - 01/2016
1Hemodiafiltration
07/2021
1Transplantation
03/2021
1Oral Surgery (Maxillofacial Surgery)
01/2021
1Tooth Extraction (Tooth Extractions)
01/2021
1Enteral Nutrition (Feeding, Tube)
11/2020